Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
oxytocin vasopressin v1a receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.59 approved unknown
oxytocin vasopressin v1a receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.59 approved agonist
oxytocin vasopressin v1a receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.59 approved unknown
oxytocin vasopressin v1a receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.59 approved agonist
oxytocin vasopressin v1b receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.79 approved agonist
oxytocin vasopressin v1b receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.79 approved agonist
oxytocin vasopressin v1b receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.79 approved unknown
oxytocin vasopressin v1b receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.79 approved unknown
oxytocin vasopressin v2 receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.57 approved agonist
oxytocin vasopressin v2 receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 0.57 approved unknown
oxytocin vasopressin v2 receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.57 approved unknown
oxytocin vasopressin v2 receptor NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.57 approved agonist
oxytocin oxytocin receptor biotech Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pervasive Development Disorder[MeSHID:D002659]
Breast Feeding[MeSHID:D001942]
Lactation[MeSHID:D007774]
Autism Spectrum Disorders[MeSHID:D000067877]		 3.35 approved,vet_approved agonist
oxytocin oxytocin receptor biotech Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Vagina[MeSHID:D014621]
Postpartum Hemorrhage[MeSHID:D006473]
Labor (Childbirth)[MeSHID:D007743]
Uterine Contraction[MeSHID:D014590]
Rupture[MeSHID:D012421]
Gestational Diabetes[MeSHID:D016640]
Uterine Inertia[MeSHID:D014593]
Rh Sensitization[MeSHID:D012203]
Hemorrhage[MeSHID:D006470]
Tissue membrane[MeSHID:D008566]
Pre-Eclampsia[MeSHID:D011225]
Term Birth[MeSHID:D047929]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.35 approved,vet_approved agonist
click here to return to the previous page